1734 logo

Sinphar Pharmaceutical Co.,Ltd. Stock Price

TWSE:1734 Community·NT$6.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1734 Share Price Performance

NT$32.00
3.05 (10.53%)
NT$32.00
3.05 (10.53%)
Price NT$32.00

1734 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet average dividend payer.

1 Risk
1 Reward

Sinphar Pharmaceutical Co.,Ltd. Key Details

NT$3.2b

Revenue

NT$1.9b

Cost of Revenue

NT$1.3b

Gross Profit

NT$1.0b

Other Expenses

NT$309.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
1.63
40.81%
9.62%
48.2%
View Full Analysis

About 1734

Founded
1977
Employees
n/a
CEO
Youyang Bai
WebsiteView website
www.sinphar.com.tw

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

Recent 1734 News & Updates

Recent updates

No updates